NASDAQ:ACMRACM Research Stock Price, Forecast & News

ACM Research's stock was trading at $25.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ACMR shares have increased by 154.2% and is now trading at $65.08. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ACM Research in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ACM Research.

ACM Research is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for ACM Research.

ACM Research Inc (NASDAQ:ACMR) released its earnings results on Wednesday, May, 6th. The specialty retailer reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.09. The specialty retailer earned $24.35 million during the quarter, compared to analysts' expectations of $19.95 million. ACM Research had a net margin of 16.83% and a return on equity of 25.64%. View ACM Research's earnings history.

ACM Research issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $130-150 million, compared to the consensus revenue estimate of $138.58 million.

7 brokerages have issued twelve-month price targets for ACM Research's stock. Their forecasts range from $31.00 to $80.00. On average, they expect ACM Research's stock price to reach $53.86 in the next year. This suggests that the stock has a possible downside of 17.2%. View analysts' price targets for ACM Research.

News headlines about ACMR stock have trended very negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ACM Research earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned news stories about the specialty retailer a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutACM Research.

ACM Research saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 1,280,000 shares, a decline of 7.2% from the April 30th total of 1,380,000 shares. Based on an average daily volume of 560,500 shares, the short-interest ratio is presently 2.3 days. Currently, 11.3% of the shares of the company are sold short. View ACM Research's Current Options Chain.

Some companies that are related to ACM Research include Brooks Automation (BRKS), IHI CORP/ADR (IHICY), Bodycote (BYPLF), Axcelis Technologies (ACLS), Veeco Instruments (VECO), Energy Recovery (ERII), Intevac (IVAC), Manitex International (MNTX), Amtech Systems (ASYS), Taronis Technologies (TRNX), CVD Equipment (CVV), Enviro Technologies (EVTN) and Greystone Logistics (GLGI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ACM Research investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Walt Disney (DIS), Crispr Therapeutics (CRSP), Micron Technology (MU), Square (SQ), salesforce.com (CRM), Roku (ROKU) and Tesla (TSLA).

(ACMR) raised $17 million in an initial public offering (IPO) on Friday, November 3rd 2017. The company issued 2,000,000 shares at a price of $7.50-$9.50 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group and The Benchmark Company were co-managers.

ACM Research trades on the NASDAQ under the ticker symbol "ACMR."

ACM Research's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Invesco Ltd. (1.47%), BlackRock Inc. (1.33%), EAM Investors LLC (0.56%), Geode Capital Management LLC (0.52%), Calamos Advisors LLC (0.48%) and Nomura Holdings Inc. (0.48%).

ACMR stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Deutsche Bank AG, Globeflex Capital L P, Calamos Advisors LLC, WINTON GROUP Ltd, Bank of New York Mellon Corp, and State Street Corp.

ACMR stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Nomura Holdings Inc., EAM Investors LLC, EAM Global Investors LLC, Oasis Management Co Ltd., Pinpoint Asset Management Ltd, Parametric Portfolio Associates LLC, and KEYWISE CAPITAL MANAGEMENT HK Ltd.

Shares of ACMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACMR stock can currently be purchased for approximately $65.08.

ACM Research has a market capitalization of $1.05 billion and generates $107.52 million in revenue each year. The specialty retailer earns $18.89 million in net income (profit) each year or $1.17 on an earnings per share basis. ACM Research employs 273 workers across the globe.

The official website for ACM Research is www.acmrcsh.com.

ACM Research's mailing address is 42307 OSGOOD ROAD SUITE I, FREMONT CA, 94539. The specialty retailer can be reached via phone at 510-445-3700 or via email at [email protected]